Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs

Eli Lilly Chief Executive Dave Ricks disclosed in an interview that approximately 700,000 seniors have initiated GLP-1 treatments since Medicare expanded coverage of obesity drugs, with the vast majority of new patients selecting Lilly products. Ricks characterized the coverage expansion as positive for the company and the broader market, noting the rollout has proceeded largely as anticipated.
The coverage operates through a temporary program called “Bridge,” which enables qualifyi